Risk Management - Disclosure of ECL under 100% weighted scenarios for key modelled portfolios (Details) - GBP (£)
£ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 1,232,975
|
£ 1,204,773
|
|
| Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(4,034)
|
(3,860)
|
|
| Loans and advances at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
150,786
|
144,827
|
|
| Loans and advances at amortised cost | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 150,786
|
£ 144,827
|
|
| Coverage ratio |
2.30%
|
2.30%
|
|
| Loans and advances at amortised cost | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 138,340
|
£ 132,198
|
|
| Coverage ratio |
0.40%
|
0.40%
|
|
| Loans and advances at amortised cost | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 10,057
|
£ 10,591
|
|
| Coverage ratio |
9.30%
|
9.10%
|
|
| Loans and advances at amortised cost | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 2,389
|
£ 2,038
|
|
| Coverage ratio |
45.90%
|
47.80%
|
|
| Loans and advances at amortised cost | Gross exposure | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 154,403
|
£ 148,247
|
|
| Loans and advances at amortised cost | Gross exposure | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
138,892
|
132,689
|
|
| Loans and advances at amortised cost | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
138,892
|
132,689
|
|
| Loans and advances at amortised cost | Gross exposure | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
11,093
|
11,654
|
|
| Loans and advances at amortised cost | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
11,093
|
11,654
|
|
| Loans and advances at amortised cost | Gross exposure | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,418
|
3,904
|
|
| Loans and advances at amortised cost | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,418
|
3,904
|
|
| Loans and advances at amortised cost | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(3,617)
|
(3,420)
|
|
| Loans and advances at amortised cost | Accumulated impairment | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(552)
|
(491)
|
|
| Loans and advances at amortised cost | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(552)
|
(491)
|
|
| Loans and advances at amortised cost | Accumulated impairment | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1,036)
|
(1,063)
|
|
| Loans and advances at amortised cost | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1,036)
|
(1,063)
|
|
| Loans and advances at amortised cost | Accumulated impairment | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,029)
|
(1,866)
|
|
| Loans and advances at amortised cost | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,029)
|
(1,866)
|
|
| Retail mortgages |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,952
|
4,956
|
|
| Retail mortgages | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 4,952
|
£ 4,956
|
|
| Coverage ratio |
0.70%
|
0.80%
|
|
| Retail mortgages | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 4,665
|
£ 4,529
|
|
| Coverage ratio |
0.20%
|
0.20%
|
|
| Retail mortgages | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 136
|
£ 149
|
|
| Coverage ratio |
0.00%
|
0.70%
|
|
| Retail mortgages | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 151
|
£ 278
|
|
| Coverage ratio |
13.70%
|
10.30%
|
|
| Retail mortgages | Gross exposure |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 4,985
|
£ 4,997
|
£ 8,362
|
| Retail mortgages | Gross exposure | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,985
|
4,997
|
|
| Retail mortgages | Gross exposure | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,674
|
4,537
|
7,257
|
| Retail mortgages | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,674
|
4,537
|
|
| Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
136
|
150
|
389
|
| Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
136
|
150
|
|
| Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
175
|
310
|
716
|
| Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
175
|
310
|
|
| Retail mortgages | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(33)
|
(41)
|
(360)
|
| Retail mortgages | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(33)
|
(41)
|
|
| Retail mortgages | Accumulated impairment | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(9)
|
(8)
|
(11)
|
| Retail mortgages | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(9)
|
(8)
|
|
| Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
(1)
|
(28)
|
| Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
(1)
|
|
| Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(24)
|
(32)
|
(321)
|
| Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(24)
|
(32)
|
|
| Retail credit cards |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
20,527
|
19,749
|
|
| Retail credit cards | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 20,527
|
£ 19,749
|
|
| Coverage ratio |
11.20%
|
11.50%
|
|
| Retail credit cards | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 18,406
|
£ 17,295
|
|
| Coverage ratio |
2.10%
|
1.90%
|
|
| Retail credit cards | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 1,740
|
£ 2,146
|
|
| Coverage ratio |
31.40%
|
27.30%
|
|
| Retail credit cards | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 381
|
£ 308
|
|
| Coverage ratio |
78.50%
|
82.10%
|
|
| Retail credit cards | Gross exposure |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 23,113
|
£ 22,306
|
27,287
|
| Retail credit cards | Gross exposure | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
23,113
|
22,306
|
|
| Retail credit cards | Gross exposure | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
18,801
|
17,629
|
22,315
|
| Retail credit cards | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
18,801
|
17,629
|
|
| Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
2,536
|
2,953
|
3,450
|
| Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
2,536
|
2,953
|
|
| Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,776
|
1,724
|
1,522
|
| Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,776
|
1,724
|
|
| Retail credit cards | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,586)
|
(2,557)
|
(2,776)
|
| Retail credit cards | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,586)
|
(2,557)
|
|
| Retail credit cards | Accumulated impairment | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(395)
|
(334)
|
(412)
|
| Retail credit cards | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(395)
|
(334)
|
|
| Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(796)
|
(807)
|
(1,138)
|
| Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(796)
|
(807)
|
|
| Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1,395)
|
(1,416)
|
(1,226)
|
| Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1,395)
|
(1,416)
|
|
| Retail other |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,128
|
3,918
|
|
| Retail other | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 4,128
|
£ 3,918
|
|
| Coverage ratio |
0.80%
|
0.80%
|
|
| Retail other | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 3,781
|
£ 3,324
|
|
| Coverage ratio |
0.20%
|
0.20%
|
|
| Retail other | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 260
|
£ 403
|
|
| Coverage ratio |
1.90%
|
0.20%
|
|
| Retail other | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 87
|
£ 191
|
|
| Coverage ratio |
18.70%
|
11.60%
|
|
| Retail other | Gross exposure |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 4,160
|
£ 3,949
|
3,411
|
| Retail other | Gross exposure | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
4,160
|
3,949
|
|
| Retail other | Gross exposure | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,788
|
3,329
|
2,734
|
| Retail other | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,788
|
3,329
|
|
| Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
265
|
404
|
369
|
| Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
265
|
404
|
|
| Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
107
|
216
|
308
|
| Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
107
|
216
|
|
| Retail other | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(32)
|
(31)
|
(45)
|
| Retail other | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(32)
|
(31)
|
|
| Retail other | Accumulated impairment | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(7)
|
(5)
|
(8)
|
| Retail other | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(7)
|
(5)
|
|
| Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(5)
|
(1)
|
(2)
|
| Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(5)
|
(1)
|
|
| Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(20)
|
(25)
|
(35)
|
| Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(20)
|
(25)
|
|
| Corporate loans |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
121,179
|
116,204
|
|
| Corporate loans | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 121,179
|
£ 116,204
|
|
| Coverage ratio |
0.80%
|
0.70%
|
|
| Corporate loans | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 111,488
|
£ 107,050
|
|
| Coverage ratio |
0.10%
|
0.10%
|
|
| Corporate loans | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 7,921
|
£ 7,893
|
|
| Coverage ratio |
2.90%
|
3.10%
|
|
| Corporate loans | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 1,770
|
£ 1,261
|
|
| Coverage ratio |
25.00%
|
23.80%
|
|
| Corporate loans | Gross exposure |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 122,145
|
£ 116,995
|
111,158
|
| Corporate loans | Gross exposure | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
122,145
|
116,995
|
|
| Corporate loans | Gross exposure | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
111,629
|
107,194
|
100,956
|
| Corporate loans | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
111,629
|
107,194
|
|
| Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
8,156
|
8,147
|
8,967
|
| Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
8,156
|
8,147
|
|
| Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
2,360
|
1,654
|
1,235
|
| Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
2,360
|
1,654
|
|
| Corporate loans | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(966)
|
(791)
|
(836)
|
| Corporate loans | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(966)
|
(791)
|
|
| Corporate loans | Accumulated impairment | Stage 1 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(141)
|
(144)
|
(179)
|
| Corporate loans | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(141)
|
(144)
|
|
| Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(235)
|
(254)
|
(309)
|
| Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(235)
|
(254)
|
|
| Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(590)
|
(393)
|
£ (348)
|
| Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(590)
|
(393)
|
|
| Total weighted model ECL | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(3,451)
|
(3,712)
|
|
| Total weighted model ECL | Loans and advances at amortised cost | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(3,400)
|
(3,700)
|
|
| Total weighted model ECL | Weighted | Loans and advances at amortised cost | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (3,451)
|
£ (3,712)
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
13.30%
|
20.00%
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 13
|
£ 9
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1
|
3
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
15
|
25
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2)
|
(5)
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Weighted | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (2)
|
£ (5)
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
1.10%
|
0.90%
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
24.80%
|
22.30%
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
75.80%
|
76.60%
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 41,195
|
£ 45,377
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,513
|
4,591
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,975
|
2,005
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,817)
|
(2,981)
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(448)
|
(422)
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(871)
|
(1,024)
|
|
| Total weighted model ECL | Weighted | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1,498)
|
£ (1,535)
|
|
| Total weighted model ECL | Weighted | Retail other | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Weighted | Retail other | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Weighted | Retail other | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Weighted | Retail other | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Weighted | Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Weighted | Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Weighted | Retail other | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Weighted | Retail other | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Weighted | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Weighted | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Weighted | Corporate loans | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.10%
|
0.10%
|
|
| Total weighted model ECL | Weighted | Corporate loans | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
2.70%
|
2.60%
|
|
| Total weighted model ECL | Weighted | Corporate loans | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
71.40%
|
73.50%
|
|
| Total weighted model ECL | Weighted | Corporate loans | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 201,622
|
£ 193,873
|
|
| Total weighted model ECL | Weighted | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
15,180
|
17,769
|
|
| Total weighted model ECL | Weighted | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
35
|
34
|
|
| Total weighted model ECL | Weighted | Corporate loans | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(632)
|
(726)
|
|
| Total weighted model ECL | Weighted | Corporate loans | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(197)
|
(237)
|
|
| Total weighted model ECL | Weighted | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(410)
|
(464)
|
|
| Total weighted model ECL | Weighted | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(25)
|
(25)
|
|
| Total weighted model ECL | Upside 2 | Loans and advances at amortised cost | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (3,213)
|
£ (3,490)
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
6.70%
|
16.00%
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 13
|
£ 9
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1
|
3
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
15
|
25
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1)
|
(4)
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 2 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1)
|
£ (4)
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
1.00%
|
0.90%
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
23.90%
|
21.60%
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
73.70%
|
74.60%
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 40,997
|
£ 45,328
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,392
|
4,516
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,975
|
2,005
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,684)
|
(2,882)
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(420)
|
(410)
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(809)
|
(976)
|
|
| Total weighted model ECL | Upside 2 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1,455)
|
£ (1,496)
|
|
| Total weighted model ECL | Upside 2 | Retail other | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 2 | Retail other | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 2 | Retail other | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 2 | Retail other | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Upside 2 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 2 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 2 | Retail other | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 2 | Retail other | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 2 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 2 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.10%
|
0.10%
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
2.30%
|
2.20%
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
71.40%
|
73.50%
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 202,562
|
£ 194,752
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
14,097
|
16,740
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
35
|
34
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(528)
|
(604)
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(172)
|
(206)
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(331)
|
(373)
|
|
| Total weighted model ECL | Upside 2 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(25)
|
(25)
|
|
| Total weighted model ECL | Upside 1 | Loans and advances at amortised cost | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (3,315)
|
£ (3,582)
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
6.70%
|
20.00%
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 13
|
£ 9
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1
|
3
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
15
|
25
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1)
|
(5)
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 1 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1)
|
£ (5)
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
1.10%
|
0.90%
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
24.30%
|
21.90%
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
74.90%
|
75.70%
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 41,089
|
£ 45,352
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,455
|
4,554
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,975
|
2,005
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,753)
|
(2,933)
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(434)
|
(417)
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(840)
|
(999)
|
|
| Total weighted model ECL | Upside 1 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1,479)
|
£ (1,517)
|
|
| Total weighted model ECL | Upside 1 | Retail other | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 1 | Retail other | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 1 | Retail other | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Upside 1 | Retail other | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Upside 1 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 1 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 1 | Retail other | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 1 | Retail other | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 1 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Upside 1 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.10%
|
0.10%
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
2.50%
|
2.40%
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
71.40%
|
73.50%
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 202,203
|
£ 194,413
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
14,510
|
17,134
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
35
|
34
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(561)
|
(644)
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(180)
|
(215)
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(356)
|
(404)
|
|
| Total weighted model ECL | Upside 1 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(25)
|
(25)
|
|
| Total weighted model ECL | Baseline | Loans and advances at amortised cost | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (3,423)
|
£ (3,678)
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
13.30%
|
20.00%
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 13
|
£ 9
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1
|
3
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
15
|
25
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2)
|
(5)
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Baseline | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (2)
|
£ (5)
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
1.10%
|
0.90%
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
24.80%
|
22.30%
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
76.10%
|
76.70%
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 41,197
|
£ 45,377
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,504
|
4,590
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,975
|
2,005
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,821)
|
(2,983)
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(450)
|
(423)
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(868)
|
(1,023)
|
|
| Total weighted model ECL | Baseline | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1,503)
|
£ (1,537)
|
|
| Total weighted model ECL | Baseline | Retail other | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Baseline | Retail other | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Baseline | Retail other | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Baseline | Retail other | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Baseline | Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Baseline | Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Baseline | Retail other | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Baseline | Retail other | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Baseline | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Baseline | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Baseline | Corporate loans | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.10%
|
0.10%
|
|
| Total weighted model ECL | Baseline | Corporate loans | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
2.60%
|
2.50%
|
|
| Total weighted model ECL | Baseline | Corporate loans | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
71.40%
|
73.50%
|
|
| Total weighted model ECL | Baseline | Corporate loans | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 201,950
|
£ 194,151
|
|
| Total weighted model ECL | Baseline | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
14,869
|
17,508
|
|
| Total weighted model ECL | Baseline | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
35
|
34
|
|
| Total weighted model ECL | Baseline | Corporate loans | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(600)
|
(690)
|
|
| Total weighted model ECL | Baseline | Corporate loans | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(188)
|
(226)
|
|
| Total weighted model ECL | Baseline | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(387)
|
(439)
|
|
| Total weighted model ECL | Baseline | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(25)
|
(25)
|
|
| Total weighted model ECL | Downside 1 | Loans and advances at amortised cost | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (3,726)
|
£ (3,942)
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
13.30%
|
20.00%
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 13
|
£ 9
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1
|
3
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
15
|
25
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2)
|
(5)
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 1 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (2)
|
£ (5)
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
1.10%
|
0.90%
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
25.80%
|
23.00%
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
77.70%
|
78.30%
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 41,419
|
£ 45,429
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,634
|
4,660
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,975
|
2,005
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2,945)
|
(3,071)
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(475)
|
(431)
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(936)
|
(1,070)
|
|
| Total weighted model ECL | Downside 1 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1,534)
|
£ (1,570)
|
|
| Total weighted model ECL | Downside 1 | Retail other | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 1 | Retail other | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 1 | Retail other | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 1 | Retail other | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Downside 1 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 1 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 1 | Retail other | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 1 | Retail other | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 1 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 1 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.10%
|
0.10%
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
3.20%
|
3.10%
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
71.40%
|
73.50%
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 200,869
|
£ 193,208
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
16,082
|
18,576
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
35
|
34
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(779)
|
(866)
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(233)
|
(272)
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(521)
|
(569)
|
|
| Total weighted model ECL | Downside 1 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(25)
|
(25)
|
|
| Total weighted model ECL | Downside 2 | Loans and advances at amortised cost | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (4,170)
|
£ (4,324)
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
13.30%
|
20.00%
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 13
|
£ 9
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1
|
3
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
15
|
25
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(2)
|
(5)
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 2 | Retail mortgages | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (2)
|
£ (5)
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
1.20%
|
1.00%
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
26.80%
|
23.70%
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
79.10%
|
79.70%
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 41,583
|
£ 45,462
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
3,837
|
4,752
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
1,975
|
2,005
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(3,092)
|
(3,163)
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(500)
|
(438)
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1,029)
|
(1,127)
|
|
| Total weighted model ECL | Downside 2 | Retail credit cards | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (1,563)
|
£ (1,598)
|
|
| Total weighted model ECL | Downside 2 | Retail other | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 2 | Retail other | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 2 | Retail other | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.00%
|
0.00%
|
|
| Total weighted model ECL | Downside 2 | Retail other | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Downside 2 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 2 | Retail other | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 2 | Retail other | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 2 | Retail other | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 2 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
0
|
0
|
|
| Total weighted model ECL | Downside 2 | Retail other | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 0
|
£ 0
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
0.10%
|
0.20%
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
3.90%
|
3.70%
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Coverage ratio |
71.40%
|
73.50%
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Gross exposure | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ 197,068
|
£ 189,985
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
20,024
|
21,956
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Gross exposure | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
35
|
34
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Accumulated impairment | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(1,076)
|
(1,156)
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Accumulated impairment | Stage 1 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(280)
|
(318)
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 2 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(771)
|
(813)
|
|
| Total weighted model ECL | Downside 2 | Corporate loans | Accumulated impairment | Lifetime expected credit losses | Stage 3 | Financial assets at amortised cost |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(25)
|
(25)
|
|
| ECL from individually assessed exposures | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(538)
|
(329)
|
|
| ECL from individually assessed exposures | Loans and advances at amortised cost | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(500)
|
(300)
|
|
| ECL from benchmarked exposures and others | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(63)
|
(103)
|
|
| ECL from benchmarked exposures and others | Loans and advances at amortised cost | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(100)
|
(100)
|
|
| ECL from debt securities at amortised cost | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(19)
|
(20)
|
|
| ECL from held for sale assets (co-branded card portfolio) | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
235
|
282
|
|
| ECL from post model management adjustments | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
(198)
|
22
|
|
| ECL from economic uncertainty adjustments | Accumulated impairment |
|
|
|
| Disclosure of nature and extent of risks arising from financial instruments [line items] |
|
|
|
| Loans and advances |
£ (80)
|
£ 0
|
|